Hadassah

Israeli Start-up’s Algorithm Predicts Which Diabetic Patients Will Suffer Kidney Dysfunction Within One Year

Wednesday, Feb 7 2018

Dr. Itamar Raz

The Israeli start-up Medial EarlySign has created a machine-learning-based model that has proven to identify diabetic patients who are at the highest risk for experiencing renal dysfunction within one year.

The Medial EarlySign's algorithm is able to identify 25 percent more patients than the current commonly used clinical tools by analyzing dozens of factors residing in Electronic Health Records, such as laboratory test results, medication, diagnostic codes, and demographics.

"The significant size and rapid growth of digital health databases now allow the application of advanced mathematical tools that can spot patterns in diverse patient populations in order to identify high-risk patients," relates Dr. Itamar Raz, Director Emeritus of the Diabetes Unit at the Hadassah Medical Organization and head of Israel’s National Diabetes Council. "Rather than relying only on small patient samples based on known risk factors,” Dr. Raz explains, “machine learning tools can reveal the slightest correlations among these parameters and discover additional risk indicators that can lead to improved prediabetic patient risk stratification (which involves classifying people into well-defined risk groups).”

By isolating less than five percent of the 400,000 diabetic patients within the company's database of 15 million patients, the algorithm was able to identify 45 percent of patients who would progress to significant kidney damage within a year. This was before they became symptomatic.

Kidney problems are one of the most common diabetes-related complications, affecting millions of people--approximately 20-40 percent of diabetics worldwide, according to Medial EarlySign. The company’s expectation is that the numbers will continue to rise as diabetes becomes more prevalent.

Learn more about the Hadassah Medical Organization.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Thursday, Apr 18 2019

Hadassah Cardiac Specialist Recognized for Lifetime Achievement

Congratulations to Hadassah Medical Organization Prof. Emeritus Andre Keren upon receiving the Lifetime Achievement Award from the European Society of Cardiology’s Working Group on Myocardial and Pericardial Diseases.

READ MORE ›
alt_text

Thursday, Apr 18 2019

Hadassah’s Pollin Center Celebrates Five Years of Women’s Wellness Achievements

Longing to commemorate the early death of her daughter from cardiovascular disease, Irene Pollin established the Linda Joy Pollin Cardiovascular Wellness Center for Women at Hadassah Hospital Ein Kerem in 2013.

READ MORE ›
alt_text

Thursday, Apr 18 2019

Pre-clinical Study by Hadassah Neurologists Sheds Light on Major Player in Alzheimer’s Disease

While scientists know a vast amount about what can go wrong in a brain afflicted with Alzheimer’s disease, they also know very little about how our brains protect themselves from such injuries, reports Prof. Tamir Ben-Hur, head of the Division of Clinical Neurosciences at the Hadassah Medical Organization.

READ MORE ›
alt_text

Wednesday, Apr 17 2019

First in Israel: Hadasit Launches Medical Startup Accelerator with IBM

Hadasit, the Hadassah Medical Organization’s technology transfer company, has launched Israel’s first biotechnology hub within a medical center.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More